Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nuclear Actin Dynamics in Gene Expression, DNA Repair, and Cancer. | Results Probl Cell Differ | 2022 | 36348125 | PubTator, text mining | PubMed |
| The effect of a traditional Chinese quadri-combination therapy and its component quercetin on recurrent spontaneous abortion: A clinical trial, network pharmacology and experiments-based study. | Front Pharmacol | 2022 | 36339549 | PubTator, text mining | PubMed |
| SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. | Redox Biol | 2022 | 36334378 | PubTator, text mining | PubMed |
| TMBIM5 is the Ca2+ /H+ antiporter of mammalian mitochondria. | EMBO Rep | 2022 | 36321428 | PubTator, text mining | PubMed |
| NFKB1 Gene Mutant Was Associated with Prognosis of Coronary Artery Disease and Exacerbated Endothelial Mitochondrial Fission and Dysfunction. | Oxid Med Cell Longev | 2022 | 36317060 | PubTator, text mining | PubMed |
| Ischemic preconditioning upregulates Mitofusin2 and preserves muscle strength in tourniquet-induced ischemia/reperfusion. | J Orthop Translat | 2022 | 36312592 | PubTator, text mining | PubMed |
| Isolation and Characterization of Primary DMD Pig Muscle Cells as an In Vitro Model for Preclinical Research on Duchenne Muscular Dystrophy. | Life (Basel) | 2022 | 36295103 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in a High Intraocular Pressure-Induced Retinal Ischemia Minipig Model. | Biomolecules | 2022 | 36291741 | PubTator, text mining | PubMed |
| The Complex Interplay between Mitochondria, ROS and Entire Cellular Metabolism. | Antioxidants (Basel) | 2022 | 36290718 | PubTator, text mining | PubMed |
| Pro-Inflammatory Cytokines Promote the Transcription of Circular RNAs in Human Pancreatic β Cells. | Noncoding RNA | 2022 | 36287121 | PubTator, text mining | PubMed |
| Naringin regulates mitochondrial dynamics to protect against acetaminophen-induced hepatotoxicity by activating the AMPK/Nrf2 signaling pathway in vitro. | Braz J Med Biol Res | 2022 | 36259797 | PubTator, text mining | PubMed |
| Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities. | Crit Rev Oncol Hematol | 2022 | 36257540 | PubTator, text mining | PubMed |
| Sanggenon C Suppresses Tumorigenesis of Gastric Cancer by Blocking ERK-Drp1-Mediated Mitochondrial Fission. | J Nat Prod | 2022 | 36256535 | PubTator, text mining | PubMed |
| Implications of notch signaling in duchenne muscular dystrophy. | Front Physiol | 2022 | 36237531 | PubTator, text mining | PubMed |
| Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model. | Int J Mol Sci | 2022 | 36232292 | PubTator, text mining | PubMed |
| Proteomic and Phosphoproteomic Profiling Reveals the Oncogenic Role of Protein Kinase D Family Kinases in Cholangiocarcinoma. | Cells | 2022 | 36231050 | PubTator, text mining | PubMed |
| TIMP-1 Dependent Modulation of Metabolic Profiles Impacts Chemoresistance in NSCLC. | Cells | 2022 | 36230997 | PubTator, text mining | PubMed |
| CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives. | Cells | 2022 | 36230926 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies. | Front Physiol | 2022 | 36225299 | PubTator, text mining | PubMed |
| Characteristics of drug-related problems and pharmacist's interventions in hospitalized patients in Thailand: a prospective observational study. | Sci Rep | 2022 | 36224350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=53